| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.147 | 34.662 | 37.445 | 35.708 | 46.546 | 58.984 | 58.465 |
| Total Income - EUR | - | - | - | 4.147 | 34.662 | 37.445 | 35.708 | 46.546 | 58.984 | 58.467 |
| Total Expenses - EUR | - | - | - | 1.689 | 26.207 | 25.617 | 32.659 | 36.187 | 44.207 | 32.233 |
| Gross Profit/Loss - EUR | - | - | - | 2.458 | 8.455 | 11.828 | 3.049 | 10.359 | 14.777 | 26.234 |
| Net Profit/Loss - EUR | - | - | - | 2.418 | 8.109 | 11.463 | 2.692 | 9.917 | 14.217 | 24.744 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nbsa Med Concept S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 52 | 20.610 | 20.220 | 19.771 | 14.887 | 13.198 | 13.124 |
| Current Assets | - | - | - | 2.968 | 5.748 | 14.437 | 7.493 | 19.117 | 36.676 | 50.666 |
| Inventories | - | - | - | 353 | 3.012 | 4.638 | 1.597 | 1.602 | 1.597 | 0 |
| Receivables | - | - | - | 1.830 | 2.590 | 2.981 | 3.026 | 15.981 | 16.660 | 2.020 |
| Cash | - | - | - | 785 | 145 | 6.819 | 2.870 | 1.533 | 18.419 | 48.646 |
| Shareholders Funds | - | - | - | 2.461 | 10.522 | 21.785 | 23.994 | 33.986 | 48.099 | 61.609 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 559 | 15.836 | 12.872 | 3.270 | 18 | 1.775 | 2.181 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nbsa Med Concept S.r.l.